| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 Feb 2025 | 27 Dec 2024 |
| Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday February 12 2025 inter alia to consider and approve Unaudited Financial Results for the Quarter ended December 31 2024. Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve Update on board meeting (As Per BSE Announcement Dated on: 31/01/2025) Find enclosed the unaudited financial results for the quarter ended December 31,2024 along with the limited review report and recommendation of interim dividend for the FY 2024-25 (As Per BSE Announcement Dated on: 12/02/2025) | ||
| Board Meeting | 4 Nov 2024 | 27 Sep 2024 |
| Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2024 inter alia to consider and approve We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday November 4 2024 inter alia to consider and approve Unaudited Financial Results for the Quarter ended September 30 2024. Find enclosed the unaudited financial results for the quarter ended September 30,2024 along with the limited review report on the same. (As per BSE Announcement Dated on 04/11/2024) | ||
| Board Meeting | 21 Aug 2024 | 27 Jun 2024 |
| Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/08/2024 inter alia to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday August 21 2024 inter alia to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30 2024 and to consider recommendation of dividend (if any). We are pleased to inform you that the Board at its meeting held today recommended a final dividend of Rs. 60 per equity share for the financial year ended June 30,2024 (As Per BSE Announcement Dated on 21.08.2024) | ||
| Board Meeting | 2 May 2024 | 27 Mar 2024 |
| Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 inter alia to consider and approve We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday May 22024 inter alia to consider and approve Unaudited Financial Results for the Quarter ended March 31 2024. Enclosed herewith are the unaudited financial results for the quarter ended March 31,2024 along with the limited review report of the auditors thereon. (As per BSE Announcement Dated on 02/05/2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
